Received Feb 16, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPVHIB | DTAP + IPV + HIB (PENTACEL) | SANOFI PASTEUR | 4 | UK333AA | OT / RL |
Patient was supposed to receive the PENTACEL but the medical assistant only gave the liquid part and did not mix with no reported adverse event; Initial information received on 11-Feb-2026 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 3 years old female patient who was supposed to receive the diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine [Pentacel (VERO)] but the medical assistant only gave the liquid part and did not mix with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Measles Vaccine, Mumps Vaccine, Rubella Vaccine (MMR); and Hepatitis A Vaccine both for Immunisation. On 09-Feb-2026, the patient received 0.5 ml of dose 4 of diphtheria/tetanus/5 hybrid AC pertussis/IPV(VERO)/HIB(PRP/T) vaccine Powder and suspension for suspension for injection with an unknown strength (expiry date- 30-SEP-2026 and lot UK333AA) via unknown route in the right thigh for Immunization and the medical assistant only gave the liquid part and did not mix with no reported adverse event (single component of a two-component product administered) (latency- same day). It was reported that, "the medical assistant (MA) who administered the dose is new at the office. She only pulled one vial from the stock for the dose, the liquid portion. The office has done training since this happened and now the MA is aware of the correct administration." Action taken was not applicable. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
MMR; HEPATITIS A VACCINE